Free Newsletter
Keep an eye on these biotech stocks
Five biotech companies that are nearing a crucial crossroad in the next two or three months. Each of them face a moment of truth that has been years in the making. This is how Liang and Schwartz of Leerink Swann see the chips falling in the weeks and months to come for Human Genome Sciences, Auxilium Pharmaceuticals, Inspire Pharmaceuticals, GTx and Poniard Pharmaceuticals. Stock report
More stories about Stock
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: